Global Oncology Market Size By Cancer Diagnostics & Treatment, (Cancer Diagnostics, Cancer Treatment), By Indication (Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer,Bladder Cancer), By End-Use (Hospitals, Diagnostic laboratories, Diagnostic imaging centers, Academia), By Geographic Scope And Forecast

Report ID: 306688|No. of Pages: 202

product image

Global Oncology Market Size By Cancer Diagnostics & Treatment, (Cancer Diagnostics, Cancer Treatment), By Indication (Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer,Bladder Cancer), By End-Use (Hospitals, Diagnostic laboratories, Diagnostic imaging centers, Academia), By Geographic Scope And Forecast

Report ID: 306688|Published Date: Feb 2024|No. of Pages: 202|Base Year for Estimate: 2021|Format:   Report available in PDF formatReport available in Excel Format

Oncology Market Size And Forecast

Oncology Market size was valued at USD 286.63 Billion in 2021 and is projected to reach USD 578.93 Billion by 2030, growing at a CAGR of 8.12 % from 2023 to 2030.

Several factors have fueled the Oncology Market, including advancements in treatment options, an aging population, and increased disease awareness. Cancer incidence is rising globally as a result of factors such as an aging population and lifestyle choices. As a result, more people are being diagnosed with cancer, creating a greater demand for Oncology treatments. However, changing customer and key player preferences are among the most important drivers of this market.

>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=306688

Oncology Market is estimated to grow at a CAGR of 8.12 % & reach US$ 578.93 Bn by the end of 2030

Global Oncology Market Definition

Oncology is the medical field concerned with cancer prevention, diagnosis, and treatment. Oncology is the going to lead therapy area for advancement in terms of clinical trial activity, the number of companies making investments in therapeutics, the size of the pipeline of therapies in clinical development, novel active substances being launched, and the amount of money spent on these drugs. Cancer care continued to be provided in 2021, despite a backlog in treatment and screenings raising concerns.

In a record-breaking year, more novel cancer medicines had become accessible for the first time compared to any other year in history, and a lot of them use immunology or precision biomarkers.
Implementation of breakthrough medicines and diagnostics is improving outcomes for millions of people all over the world, but broad and equitable access continues to be a significant challenge for healthcare stakeholders, including patients.

The advancements in the pharmaceutical industry over the last few years have made cancer more treatable. The increasing prevalence of cancer has resulted in an increase in the global demand for cancer drugs. The oncology drugs that are commonly used in cancer diagnosis are determined by the stage of progression. Oncology drugs can treat a variety of cancers, including blood cancer, skin cancer, lung cancer, breast cancer, gastrointestinal cancer, and bone cancer.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

vmr

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=306688

Global Oncology Market Overview

Preventive the global Oncology Market is experiencing growth because of the rising consumption of alcohol and tobacco. According to the International Agency for Research on Cancer (IARC) report GLOBOCAN, approximately 19.3 million new cancer cases, and approximately 10 million cancer-related deaths were recorded globally in 2020. According to the IARC, new cancer cases are expected to rise by 47% worldwide between 2020 and 2040.

As a result, the increasing prevalence of cancer is expected to encourage the implementation of oncology diagnostics and oncology treatment around the world, enhancing the global Oncology Market’s growth. Furthermore, increasing initiatives by the government and various non-profit organizations to raise awareness about cancer prevention are projected to drive market expansion. The World Health Organization’s Global Action Plan for the Prevention and Control of Noncommunicable Diseases, for example, aims to reduce premature death from cancer, cardiovascular disease, chronic respiratory diseases, and diabetes by around 25% by 2025.

The increased incidences of various chronic diseases have increased the global demand for early cancer detection and treatment. Increasing investment and advancements in the biopharmaceutical industry are encouraging the development of new drugs and therapeutics, which stimulates the economy for oncology treatment and diagnostics. The growing public awareness of the availability of various oncology drugs and diagnostics is projected to propel worldwide Oncology Market growth. As a result, market participants are enticed to invest in the Oncology Market due to its growing importance and higher profit potential.

Global Oncology Market: Segmentation Analysis

The Global Oncology Market is Segmented on the basis of Cancer Diagnostics & Treatment, Indication, End-Use, And Geography.

Oncology Market Segmentation Analysis

Oncology Market, By Cancer Diagnostics & Treatment

  • Cancer Diagnostics
  • Cancer Treatment

Based on Cancer Diagnostics & Treatment, the market is split into Cancer Diagnostics and Cancer Treatment. The Oncology Market was dominated by the cancer treatment segment. This is due to the increased use of traditional chemotherapy and immunotherapy for cancer treatment around the world. People are increasingly turning to targeted therapy and immunotherapy for cancer treatment because they are more advantageous, effective, and have fewer side effects than traditional chemotherapy. The low toxicity and ability of targeted therapy to specifically target cancer cells without harming normal cells are markedly boosting the growth of the cancer treatment segment. Furthermore, rising public awareness of the benefits of targeted therapy, hormonal therapy, and immunotherapy is fueling requirements for these cancer treatments among worldwide cancer patients.

Oncology Market, By Indication

  • Lungs Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Liver Cancer
  • Bladder Cancer
  • Head & Neck Cancer
  • Prostate Cancer
  • Others

Based on Indication, The market is split into Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, and Others. Due to an increase in lung cancer cases worldwide, the lung cancer segment dominated the market. According to the International Agency for Research on Cancer, there will be approximately 1.8 million deaths from lung cancer in 2020. Lung cancer is the most common type of cancer in the world, accounting for approximately 18% of cancer deaths worldwide. It is widely acknowledged to be the leading cause of cancer deaths. The increased global incidence of tobacco use is a major factor driving the growth of this segment. During the forecast period, breast cancer is expected to be the fastest-growing market. This is due to the rising prevalence of breast cancer among females. According to the IARC, breast cancer has exceeded lung cancer as the most commonly diagnosed type of cancer.

Oncology Market, By End-Use

  • Hospitals
  • Diagnostic laboratories
  • Diagnostic imaging centers
  • Academia
  • Specialty clinics
  • Others

Based on End-Use, The market is split into Hospitals, Diagnostic Laboratories, Diagnostic imaging centers, Academia, Specialty clinics, and Others. During the forecast period, the hospital segment is expected to be dominant. The rising prescription of medications at hospitals because of more frequent diagnoses at these institutions is the reason for this segment’s dominance. This is related to the need for drugs in hospitals and clinics, as well as the ease with which physicians and patients can obtain the appropriate type of drug in hospitals. The global pandemic of COVID-19 prompted an increase in visits. As a result of more people visiting hospitals, we would see an increase in prescriptions delivered and, as a result, an increase in sales of cancer drugs.

Oncology Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Oncology Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa based on the regional analysis. North America dominated the global Oncology Market. It can be caused by the rising prevalence of cancer in a major market like the United States. According to the American Cancer Society, over 1.8 million new cancer cases and 606,520 deaths were reported in the United States in 2020. Lung cancer, colorectal cancer, breast cancer, and prostate cancer are the most common cancers in North America. The involvement of established healthcare systems and increased healthcare expenditure is anticipated to keep the North American Oncology Market prominent.

Key Players

The “Global Oncology Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Roche Holding AG, Novartis AG, Johnson & Johnson, Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Amgen Inc., AbbVie Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Celgene Corporation, Bayer AG, Gilead Sciences, Inc., and other prominent players.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and global market ranking analysis of the above-mentioned players. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments:

 Oncology Market Key Developments And Mergers

  • In April 2020, In India, F. Hoffman-La Roche initiated Atezolizumab, an immunotherapy medicine used to treat breast cancer.
  • In May 2019, Syapse and Amgen, Inc. formed a partnership to conduct observational analytics research to evaluate clinical outcomes in unmet oncology needs.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.Ace Matrix Analysis of Oncology Market

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Oncology market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.Geographical Representation of Oncology Market

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in Global Oncology Market gauge the attractiveness of a certain sector, and assess investment possibilities.

Porter\'s Five Forces Framework of Oncology Market

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2018-2030

Base Year

2021

Forecast Period

2023-2030

Historical Period

2018-2020

Unit

Value (USD Billion)

Key Companies Profiled

Roche Holding AG, Novartis AG, Johnson & Johnson, Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Amgen Inc.

Segments Covered

By Cancer Diagnostics & Treatment, By Indication, By End-Use, and By Geography.

Customization Scope

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports:

Global Digital Patient Monitoring Devices Size And Forecast

Global Cardiovascular Devices Market Size And Forecast

Global Healthcare Provider Network Management Market Size And Forecast

Research Methodology of Verified Market Research:

Research Methodology of VMR

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Oncology Market was valued at USD 286.63 Billion in 2021 and is projected to reach USD 578.93 Billion by 2030, growing at a CAGR of 8.12 % from 2023 to 2030.

Several factors have fueled the Oncology Market, including advancements in treatment options, an aging population, and increased disease awareness.

The major players are Roche Holding AG, Novartis AG, Johnson & Johnson, Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Amgen Inc., AbbVie Inc.

The Global Oncology Market is Segmented on the basis of Cancer Diagnostics & Treatment, Indication, End-Use, And Geography.

The sample report for the Oncology Market can be obtained on demand from the website. Also, 24*7 chat support & direct call services are provided to procure the sample report.
1 INTRODUCTION OF GLOBAL ONCOLOGY MARKET 1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions 2 EXECUTIVE SUMMARY 3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH 3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources 3.5 Market attractiveness 4 GLOBAL ONCOLOGY MARKET OUTLOOK 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis 5 GLOBAL ONCOLOGY MARKET, BY CANCER DIAGNOSTICS & TREATMENT 5.1 Cancer Diagnostics 5.2 Cancer Treatment 6 GLOBAL ONCOLOGY MARKET, BY INDICATION 6.1 Lungs Cancer 6.2 Colorectal Cancer 6.3 Breast Cancer 6.4 Liver Cancer 6.5 Bladder Cancer 6.6 Head & Neck Cancer 6.7 Prostate Cancer 6.8 Others 7 GLOBAL ONCOLOGY MARKET, BY END-USE 7.1 Hospitals 7.2 Diagnostic laboratories 7.3 Diagnostic imaging centers 7.4 Academia 7.5 Specialty clinics 7.6 Others 8 GLOBAL ONCOLOGY MARKET, BY GEOGRAPHY 8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Italy 8.3.5 Spain 8.3.6 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Latin America 8.5.1 Brazil 8.5.2 Argentina 8.5.3 Rest of Latin America 8.6 Middle East and Africa 8.6.1 UAE 8.6.2 Saudi Arabia 8.6.3 South Africa 8.6.4 Rest of Middle East and Africa 9 GLOBAL ONCOLOGY MARKET COMPETITIVE LANDSCAPE 9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies 9.4 ACE Matrix 10 COMPANY PROFILES 10.1 Roche Holding AG 10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments 10.2 Novartis AG 10.2.1 Overview 10.2.2 Financial Performance 10.2.3 Product Outlook 10.2.4 Key Developments 10.3 Johnson & Johnson 10.3.1 Overview 10.3.2 Financial Performance 10.3.3 Product Outlook 10.3.4 Key Developments 10.4 Pfizer Inc. 10.4.1 Overview 10.4.2 Financial Performance 10.4.3 Product Outlook 10.4.4 Key Developments 10.5 Merck & Co., Inc. 10.5.1 Overview 10.5.2 Financial Performance 10.5.3 Product Outlook 10.5.4 Key Developments 10.6 Bristol-Myers Squibb Company 10.6.1 Overview 10.6.2 Financial Performance 10.6.3 Product Outlook 10.6.4 Key Development 10.7 AstraZeneca plc 10.7.1 Overview 10.7.2 Financial Performance 10.7.3 Product Outlook 10.7.4 Key Developments 10.8 Amgen Inc. 10.8.1 Overview 10.8.2 Financial Performance 10.8.3 Product Outlook 10.8.4 Key Development 10.9 AbbVie Inc. 10.9.1 Overview 10.9.2 Financial Performance 10.9.3 Product Outlook 10.9.4 Key Development 10.10 Sanofi S.A. 10.10.1 Overview 10.10.2 Financial Performance 10.10.3 Product Outlook 10.10.4 Key Development 10.11 Takeda Pharmaceutical Company Limited 10.11.1 Overview 10.11.2 Financial Performance 10.11.3 Product Outlook 10.11.4 Key Development 10.12 Eli Lilly and Company 10.12.1 Overview 10.12.2 Financial Performance 10.12.3 Product Outlook 10.12.4 Key Development 10.13 Celgene Corporation 10.13.1 Overview 10.13.2 Financial Performance 10.13.3 Product Outlook 10.13.4 Key Development 10.14 Bayer AG 10.14.1 Overview 10.14.2 Financial Performance 10.14.3 Product Outlook 10.14.4 Key Development 10.15 Gilead Sciences, Inc. 10.15.1 Overview 10.15.2 Financial Performance 10.15.3 Product Outlook 10.15.4 Key Development 11 KEY DEVELOPMENTS 11.1 Product Launches/Developments 11.2 Mergers and Acquisitions 11.3 Business Expansions 11.4 Partnerships and Collaborations 12 Appendix 12.1 Related Research

Report Research Methodology

Research methodology

Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.

This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.

We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:

Exploratory data mining

Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.

All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.

expert data mining

For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.

Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.

Data Collection Matrix

PerspectivePrimary ResearchSecondary Research
Supplier side
  • Fabricators
  • Technology purveyors and wholesalers
  • Competitor company’s business reports and newsletters
  • Government publications and websites
  • Independent investigations
  • Economic and demographic specifics
Demand side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customer

Econometrics and data visualization model

data visualiztion model

Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.

All the research models are customized to the prerequisites shared by the global clients.

The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.

Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.

Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.

Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:

  • Market drivers and restraints, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2027

We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.

Primary validation

The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.

The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.

primary validation

Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:

  • Established market players
  • Raw data suppliers
  • Network participants such as distributors
  • End consumers

The aims of doing primary research are:

  • Verifying the collected data in terms of accuracy and reliability.
  • To understand the ongoing market trends and to foresee the future market growth patterns.

Industry Analysis Matrix

Qualitative analysisQuantitative analysis
  • Global industry landscape and trends
  • Market momentum and key issues
  • Technology landscape
  • Market’s emerging opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2027
  • Market revenue estimates and forecasts up to 2027, by technology
  • Market revenue estimates and forecasts up to 2027, by application
  • Market revenue estimates and forecasts up to 2027, by type
  • Market revenue estimates and forecasts up to 2027, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Oncology Market

report-detail

Download Sample Report

View More Reports